Li, Chengwen
Samulski, R. Jude
Article History
Accepted: 3 December 2019
First Online: 10 February 2020
Competing interests
: R.J.S. is the founder and a shareholder at Asklepios BioPharmaceutical and Bamboo Therapeutics, Inc. He holds patents that have been licensed by University of North Carolina to Asklepios Biopharmaceutical, for which he receives royalties. He has consulted for Baxter Healthcare and has received payment for speaking. C.L. is a cofounder of Bedrock Therapeutics, Inc. He holds patents licensed by University of North Carolina and has received royalties from Bedrock Therapeutics and Asklepios Biopharmaceutical.